CIK: 0001668029
Total reported value
$97.0M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | AVIR | Atea Pharmaceuticals INC | Stock-Other | 48.35% | — | — | |
| 2 | LUNG | Pulmonx CORP | Stock-Other | 36.18% | — | — | |
| 3 | ✓ | Abg Acquisition CORP I | Stock-Other | 12.94% | — | — | |
| 4 | AGLEUSD | Aeglea Biotherapeutics INC | Stock-Other | 2.32% | — | — | |
| 5 | ✓ | Diffusion Pharmaceuticals In | Stock-Other | 0.21% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | LUNG | Pulmonx CORP | -63.8% | — | Unchanged |
| 2 | AVIR | Atea Pharmaceuticals INC | — | NEW | New buy |
| 3 | ✓ | Abg Acquisition CORP I | — | NEW | New buy |
| 4 | AGLEUSD | Aeglea Biotherapeutics INC | — | NEW | New buy |
| 5 | ✓ | Diffusion Pharmaceuticals In | — | NEW | New buy |